Behold the Body. Electron microgram of a Biondi body shows a dense core surrounded by filaments that bind gold-labeled secondary antibody to TMEM239 (black dots). [Courtesy of Ghetti et al., 2024.] ...
Alzheimer’s disease is a long, slow neurodegenerative calamity, and scientists are still hunting for blood biomarkers that reflect all its specific stages. At the Clinical Trials on Alzheimer’s ...
Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Direct costs limited to $225,000 per year and $450,000 over the 3-year project period.
Award budgets are composed of salary and additional expenses. NIH will fund up to $42,500 per year in salary. NIH will fund up to $28,656 for additional expenses such as fringe benefits (e.g., health ...
MD - University of North Carolina MBA - Kenan-Flagler Business School @ UNC MS Neuroscience - Tulane University Radiology Residency - Weill Cornell Fellowship Neuroradiology - Massachusetts General ...
Mivelsiran docks APP products in early AD. Phase 2 trial asks: Can it treat CAA? LX1001 gene therapy boosts CSF ApoE2, stabilizes AD biomarkers. Intranasal insulin quells systemic inflammation. These ...
What if there were a way to triple the speed of MRI scans without losing resolution? At the Clinical Trials on Alzheimer’s Disease conference, held October 29 to November 1 in Madrid, Spain, Miguel ...
What if there were a way to triple the speed of MRI scans without losing resolution? At the Clinical Trials on Alzheimer’s Disease conference, held October 29 to November 1 in Madrid, Spain, Miguel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback